Nutrikinetics: Concept, technologies, applications, perspectives

Trends in Food Science and Technology

Volumn 26, Issue 1, 2012, Pages 4-13

  van Duynhoven, J P M ^a,c,d   van Velzen, E J J ^a,d   Westerhuis, J A ^b,d   Foltz, M ^a,d   Jacobs, D M ^a,d   Smilde, A K ^b,d  

^a UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d NETHERLANDS METABOLOMICS CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EXOGENOUS METABOLITES; EXPLICIT MODELS; FOOD MATRIXES; METABOLIC PROFILING; PHYTOCHEMICALS; SYSTEMIC CIRCULATION;

BIOTECHNOLOGY;

FOOD TECHNOLOGY;

EID: 84863008456     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2012.01.004     Document Type: Review

References (81)

1. Abdel-Rahman S.M., Kauffman R.E. The integration of pharmacokinetics and pharmacodynamics: understanding dose-response. Annual Review of Pharmacology and Toxicology 2004, 44:111-136.
2. Appeldoorn M.M., Vincken J.P., Aura A.M., Hollman P.C.H., Gruppen H. Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites. Journal of Agricultural and Food Chemistry 2009, 57:1084-1092.
3. Arumugam M., Raes J., Pelletier E., Le Paslier D., Yamada T., Mende D.R., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
4. Blaut M., Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. Journal of Nutrition 2007, 137:751S-755S.
5. Bolling B.W., Court M.H., Blumberg J.B., Chen C.Y.O. The kinetic basis for age-associated changes in quercetin and genistein glucuronidation by rat liver microsomes. Journal of Nutritional Biochemistry 2010, 21:498-503.
6. Brochot C., Toth J., Bois F.Y. Lumping in pharmacokinetics. Journal of Pharmacokinetics and Pharmacodynamics 2005, 32:719-736.
7. Cerda B., Tomas-Barberan F.A., Espin J.C. Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. Journal of Agricultural and Food Chemistry 2005, 53:227-235.
8. Chen X., Yin O.Q.P., Zuo Z., Chow M.S.S. Pharmacokinetics and modeling of quercetin and metabolites. Pharmaceutical Research 2005, 22:892-901.
9. Claus S.P., Tsang T.M., Wang Y.L., Cloarec O., Skordi E., Martin F.P., et al. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Molecular Systems Biology 2008, 4:1-14.
10. Clavel T., Fallani M., Lepage P., Levenez F., Mathey J., Rochet V., et al. Isoflavones and functional foods alter the dominant intestinal microbiota in postmenopausal women. Journal of Nutrition 2005, 135:2786-2792.
11. Clayton T.A., Baker D., Lindon J.C., Everett J.R., Nicholson J.K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:14728-14733.
12. Crozier A., Del Rio D., Clifford M.N. Bioavailability of dietary flavonoids and phenolic compounds. Molecular Aspects of Medicine 2010, 31:446-467.
13. Daykin C.A., Van Duynhoven J.P.M., Groenewegen A., Dachtler M., Van Amelsvoort J.M.M., Mulder T.P.J. Nuclear magnetic resonance spectroscopic based studies of the metabolism of black tea polyphenols in humans. Journal of Agricultural and Food Chemistry 2005, 53:1428-1434.
14. Del Rio D., Calani L., Cordero C., Salvatore S., Pellegrini N., Brighenti F. Bioavailability and catabolism of green tea flavan-3-ols in humans. Nutrition 2011, 26:1110-1116.
15. Duchateau G.S.M.J., Klaffke W. Product composition, structure, and bioavailability. Food Biophysics 2008, 3:207-212.
16. van Duynhoven J., Vaughan E.E., Jacobs D.M., Kemperman R.A., Van Velzen E.J.J., Gross G., et al. Metabolic fate of polyphenols in the human superorganism. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:4531-4538.
17. Eeckhaut E., Struijs K., Possemiers S., Vincken J.P., Keukeleire D.D., Verstraete W. Metabolism of the lignan macromolecule into enterolignans in the gastrointestinal lumen as determined in the simulator of the human intestinal microbial ecosystem. Journal of Agricultural and Food Chemistry 2008, 56:4806-4812.
18. Fardet A., Llorach R., Orsoni A., Martin C.F., Pujos-Guillot E., Lapierre C., et al. Metabolomics provide new insight on the metabolism of dietary phytochemicals in rats. Journal of Nutrition 2008, 138:1282-1287.
19. Fave G., Draper J., Mathers J. Measurement of dietary exposure: a challenging problem which may be overcome thanks to metabolomics?. Genes and Nutrition 2009, 4:135-141.
20. Feng Y., Pollock B.G., Coley K., Marder S., Miller D., Kirshner M., et al. Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study. British Journal of Clinical Pharmacology 2008, 66:629-639.
21. Garrido I., Monagas M., Gomez-Cordoves C., Martin-Alvarez P., Llorach R. Targeted analysis of conjugated and microbial-derived phenolic metabolites in human urine after consumption of an almond skin phenolic extract. Journal of Nutrition 2010, 140:1799-1807.
22. Geldof M., Freijer J., van Beijsterveldt L., Timmerman P., Ahnaou A., Drinkenburg W.H.I.M., et al. Population pharmacokinetic model of fluvoxamine in rats: utility for application in animal behavioral studies. European Journal of Pharmaceutical Sciences 2007, 30:45-55.
23. Gibaldi M., Perrier D. Pharmacokinetics 2007, Vol. 15. Informa Healthcare, New York. 2 ed.
24. Gibney M.J., Walsh M., Brennan L., Roche H.M., German B., Van Ommen B. Metabolomics in human nutrition: opportunities and challenges. American Journal of Clinical Nutrition 2005, 82:497-503.
25. Gonthier M.P., Verny M.A., Besson C., Remesy C., Scalbert A. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. Journal of Nutrition 2003, 133:1853-1859.
26. Goodacre R. Metabolomics of a superorganism. Journal of Nutrition 2007, 137:259S-266S.
27. Gross G., Jacobs D.M., Peters S., Possemiers S., van Duynhoven J., Vaughan E.E., et al. In vitro bioconversion of polyphenols from black tea and red wine/grape juice by human intestinal microbiota displays strong interindividual variability. Journal of Agricultural and Food Chemistry 2010, 58:10236-10246.
28. Grun C.H., Van Dorsten F.A., Jacobs D.M., Le B.M., van Velzen E.J., Bingham M.O., et al. GC-MS methods for metabolic profiling of microbial fermentation products of dietary polyphenols in human and in vitro intervention studies. Journal of Chromatography B 2008, 871:212-219.
29. Gu L., Rooney L., Prior R. Sorghum bran in the diet dose dependently increased the excretion of catechins and microbial-derived phenolic acids in female rats. Journal of Agricultural and Food Chemistry 2007, 55:5326-5334.
30. Heinzmann S.S., Brown I.J., Chan Q., Bictash M., Dumas M.E., Kochhar S., et al. Metabolic profiling strategy for discovery of nutritional biomarkers: proline betaine as a marker of citrus consumption. American Journal of Clinical Nutrition 2010, 92:436-443.
31. Holmes E., Loo R.L., Stamler J., Bictash M., Yap I.K., Chan Q., et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008, 453. 396-U50.
32. Holmes E., Wilson I.D., Nicholson J.K. Metabolic phenotyping in health and disease. Cell 2008, 134:714-717.
33. Jacobs D.M., Deltimple N., Van Velzen E.J.J., Van Dorsten F.A., Bingham M., Vaughan E.E., et al. H-1 NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR in Biomedicine 2008, 21:615-626.
34. Jacobs D.M., Gaudier E., van D.J., Vaughan E.E. Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics. Current Drug Metabolism 2009, 10:41-54.
35. Kutschera M., Engst W., Blaut M., Braune A. Isolation of catechin-converting human intestinal bacteria. Journal of Applied Microbiology 2011, 111:165-175.
36. Lan K., Jia W. An integrated metabolomics and pharmacokinetics strategy for multi-component drugs evaluation. Current Drug Metabolism 2010, 11:105-114.
37. Lavielle M., Mentre F. Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software. Journal of Pharmacokinetics and Pharmacodynamics 2007, 34:229-249.
38. Lederberg J., Mccray A.T. 'Ome sweet 'omics - a genealogical treasury of words. Scientist 2001, 15:8.
39. Li M., Wang B.H., Zhang M.H., Rantalainen M., Wang S.Y., Zhou H.K., et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:2117-2122.
40. Lindon J.C., Nicholson J.K. Analytical technologies for metabonomics and metabolomics, and multi-omic information recovery. Trac-Trends in Analytical Chemistry 2008, 27:194-204.
41. Macfarlane G.T., Macfarlane S. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut. Current Opinion in Biotechnology 2007, 18:156-162.
42. Manach C., Hubert J., Llorach R., Scalbert A. The complex links between dietary phytochemicals and human health deciphered by metabolomics. Molecular Nutrition & Food Research 2009, 53:1303-1315.
43. Martin F.P., Dumas M.E., Wang Y., Legido-Quigley C., Yap I.K., Tang H., et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Molecular Systems Biology 2007, 3:112.
44. Martin F.P.J., Wang Y.L., Sprenger N., Yap I.K.S., Rezzi S., Ramadan Z., et al. Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. Molecular Systems Biology 2008, 4.
45. Martin F.P., Sprenger N., Yap I.K.S., Wang Y., Bibiloni R., Rochat F., et al. Panorganismal gut microbiomea host metabolic crosstalk. Journal of Proteome Research 2009, 8:2090-2105.
46. Mertens-Talcott S.U., Rios J., Jilma-Stohlawetz P., Pacheco-Palencia L.A., Meibohm B., Talcott S.T., et al. Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers. Journal of Agricultural and Food Chemistry 2008, 56:7796-7802.
47. Montoliu I., Martin F.P.J., Collino S., Rezzi S., Kochhar S. Multivariate modeling strategy for intercompartmental analysis of tissue and plasma H-1 NMR spectrotypes. Journal of Proteome Research 2009, 8:2397-2406.
48. Nicholson J.K. Global systems biology, personalized medicine and molecular epidemiology. Molecular Systems Biology 2006, 2:1-6.
49. Nicholson J.K., Lindon J.C. Systems biology - metabonomics. Nature 2008, 455:1054-1056.
50. Nicholson J.K., Wilson I.D., Lindon J.C. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics 2011, 12:103-111.
51. van Ommen B., Keijer J., Kleemann R., Elliott R., Drevon C.A., McArdle H., et al. The challenges for molecular nutrition research 2: quantification of the nutritional phenotype. Genes and Nutrition 2008, 3:51-59.
52. O'Sullivan A., Gibney M.J., Brennan L. Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. American Journal of Clinical Nutrition 2011, 93:314-321.
53. Rezzi S., Ramadan Z., Fay L.B., Kochhar S. Nutritional metabonomics: applications and perspectives. Journal of Proteome Research 2007, 6:513-525.
54. Roowi S., Mullen W., Edwards C.A., Crozier A. Yoghurt impacts on the excretion of phenolic acids derived from colonic breakdown of orange juice flavanones in humans. Molecular Nutrition & Food Research 2009, 53:S68-S75.
55. Sang S., Yang I., Buckley B., Yang C. Human urinary metabolite profile of tea polyphenols analyzed by liquid chromatography/electrospray ionization tandem mass spectrometry with data-dependent acquisition. Rapid Communications Mass Spectrometry 2008, 22:1567-1578.
56. Scalbert A., Brennan L., Fiehn O., Hankemeier T., Kristal B.S., Van Ommen B., et al. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics 2009, 5:435-458.
57. Seeram N.P., Henning S., Lee R.P., Niu Y.T., Zhang Y.J., Suchard M., et al. Pharmacokinetics and ex-vivo bioactivties of pomegranate polyphenols in humans. Faseb Journal 2006, 20:A1019.
58. Selma M.V., Espin J.C., Tomas-Barberan F.A. Interaction between phenolics and gut microbiota: role in human health. Journal of Agricultural and Food Chemistry 2009, 57:6485-6501.
59. Smilde A.K., Westerhuis J.A., Hoefsloot H.C.J., Bijlsma S., Rubingh C.M., Vis D.J., et al. Dynamic metabolomic data analysis: a tutorial review. Metabolomics 2010, 6:3-17.
60. Spencer J.P.E., Mohsen M.M.A., Minihane A.M., Mathers J.C. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. British Journal of Nutrition 2008, 99:12-22.
61. Stella C., Beckwith-Hall B., Cloarec O., Holmes E., Lindon J.C., Powell J., et al. Susceptibility of human metabolic phenotypes to dietary modulation. Journal of Proteome Research 2006, 5:2780-2788.
62. Urpi-Sarda M., Khan N., Monagas M., Rotches-Ribalta M., Lamuela-Raventos R. Effect of milk on the urinary excretion of microbial phenolic acids after cocoa powder consumption in humans. Journal of Agricultural and Food Chemistry 2010, 58:4706-4711.
63. Van Dorsten F.A., Grun C.H., Van Velzen E.J.J., Jacobs D.M., Draijer R., Van Duynhoven J.P.M. The metabolic fate of red wine and grape juice polyphenols in humans assessed by metabolomics. Molecular Nutrition & Food Research 2010, 54:897-908.
64. Van Ommen B., Bouwman J., Dragsted L.O., Drevon C.A., Elliott R., de Groot P., et al. Challenges of molecular nutrition research 6: the nutritional phenotype database to store, share and evaluate nutritional systems biology studies. Genes and Nutrition 2010, 5:189-203.
65. Van Ommen B., Keijer J., Heil S.G., Kaput J. Challenging homeostasis to define biomarkers for nutrition related health. Molecular Nutrition & Food Research 2009, 53:795-804.
66. Van Velzen E.J.J., Westerhuis J.A., Van Duynhoven J.P., Van Dorsten F.A., Hoefsloot H.C., Smit S., et al. Multilevel data analysis in crossover-designed human intervention studies. Journal of Proteome Research 2008, 7:4483-4491.
67. van Velzen, E. J. (2010). PhD Thesis, University of Amsterdam.
68. van Velzen E.J., Westerhuis J.A., Van Duynhoven J.P., Van Dorsten F.A., Grun C.H., Jacobs D.M., et al. Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites. Journal of Proteome Research 2009, 8:3317-3330.
69. de Vos W.M., Castenmiller J.J.M., Hamer R.J., Brummer R.J.M. Nutridynamics - studying the dynamics of food components in products and in the consumer. Current Opinion in Biotechnology 2006, 17:217-225.
70. Waldram A., Holmes E., Wang Y.L., Rantalainen M., Wilson I.D., Tuohy K.M., et al. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. Journal of Proteome Research 2009, 8:2361-2375.
71. Walsh M.C., Brennan L., Malthouse P.G., Roche H.M., Gibney M.J. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. American Journal of Clinical Nutrition 2006, 84:531-539.
72. Westerhuis J.A., Derks E.P.P.A., Hoefsloot H.C.J., Smilde A.K. Grey component analysis. Journal of Chemometrics 2007, 21:474-485.
73. Westerhuis J.A., Hoefsloot H.C.J., Smit S., Vis D.J., Smilde A.K., Van Velzen E.J.J., et al. Assessment of PLSDA cross validation. Metabolomics 2008, 4:81-89.
74. Westerhuis J.A., van Velzen E.J., Hoefsloot H.C., Smilde A.K. Multivariate paired data analysis: multilevel PLSDA versus OPLSDA. Metabolomics 2010, 6:119-128.
75. Westerhuis J., van Velzen E., Hoefsloot H., Smilde A. Discriminant Q2 (DQ2) for improved discrimination in PLSDA models. Metabolomics 2008, 4:293-296.
76. Wikoff W.R., Anfora A.T., Liu J., Schultz P.G., Lesley S.A., Peters E.C., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:3698-3703.
77. Williamson G., Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. American Journal of Clinical Nutrition 2005, 81:243S-255S.
78. Winnike J.H., Busby M.G., Watkins P.B., O'Connell T.M. Effects of a prolonged standardized diet on normalizing the human metabolome. American Journal of Clinical Nutrition 2009, 90:1496-1501.
79. Wishart D.S. Metabolomics: applications to food science and nutrition research. Trends in Food Science & Technology 2008, 19:482-493.
80. Wishart D.S. Quantitative metabolomics using NMR. Trac-Trends in Analytical Chemistry 2008, 27:228-237.
81. Xu J.J., Yang S.Y., Cai S.H., Dong J.Y., Li X.J., Chen Z. Identification of biochemical changes in lactovegetarian urine using H-1 NMR spectroscopy and pattern recognition. Analytical and Bioanalytical Chemistry 2010, 396:1451-1463.